Andy Sassine sold $1.6M of ARCT
Chief Financial Officer at Arcturus Therapeutics Holdings Inc.. 50,000 shares at an average of $32.03, traded Jun 12, 2024, filed Jun 14, 2024.
Score components
- +22RoleCFO
- +25Trade size$1.6M at market
- +5Share of holdings soldSold 18% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193805-24-000801, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 12, 2024 | SOpen-market sale Common Stock | -50,000 | $32.03 | $1.6M | 220,526 | Jun 14, 2024 |
Related signals
Other insiders at Arcturus Therapeutics Holdings Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | ARCTbuy Arcturus Therapeutics Holdings Inc. | Andy Sassine Chief Financial Officer | $20k 1,238 shares | +1% | |
| 21Weak | ARCTbuy Arcturus Therapeutics Holdings Inc. | Andy Sassine Chief Financial Officer | $20k 1,238 shares | +1% | |
| 13Weak | Arcturus Therapeutics Holdings Inc. | Pad Chivukula Chief Scientific Officer & COO | $249k 12,000 shares | -3% | |
| 8Weak | Arcturus Therapeutics Holdings Inc. | Pad Chivukula Chief Scientific Officer & COO | $5,130 114 shares | -0% | |
| 33Weak | Arcturus Therapeutics Holdings Inc. | Pad Chivukula Chief Scientific Officer & COO | $1.0M 26,000 shares | -5% | |
| 20Weak | Arcturus Therapeutics Holdings Inc. | Pad Chivukula Chief Scientific Officer & COO | $611k 17,435 shares | -4% | |
| 14Weak | Arcturus Therapeutics Holdings Inc. | Pad Chivukula Chief Scientific Officer & COO | $300k 8,565 shares | -2% | |
| 10Weak | Arcturus Therapeutics Holdings Inc. | Pad Chivukula Chief Scientific Officer & COO | $94k 5,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.